Global Procalcitonin Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Procalcitonin Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

According to APO Research, The global Procalcitonin market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Procalcitonin include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology and Wuhan Easy Diagnosis Biomedicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Procalcitonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin.
The Procalcitonin market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Procalcitonin segment by Type

Procalcitonin Antigen
Procalcitonin Antibody
Procalcitonin segment by Application

Medical Industry
Scientific Research
Veterinarian
Procalcitonin by Distribution Channel

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Procalcitonin Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Procalcitonin Sales Estimates and Forecasts (2019-2030)
1.3 Procalcitonin Market by Type
1.3.1 Procalcitonin Antigen
1.3.2 Procalcitonin Antibody
1.4 Global Procalcitonin Market Size by Type
1.4.1 Global Procalcitonin Market Size Overview by Type (2019-2030)
1.4.2 Global Procalcitonin Historic Market Size Review by Type (2019-2024)
1.4.3 Global Procalcitonin Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Procalcitonin Sales Breakdown by Type (2019-2024)
1.5.2 Europe Procalcitonin Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Procalcitonin Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Procalcitonin Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Procalcitonin Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Procalcitonin Industry Trends
2.2 Procalcitonin Industry Drivers
2.3 Procalcitonin Industry Opportunities and Challenges
2.4 Procalcitonin Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Procalcitonin Revenue (2019-2024)
3.2 Global Top Players by Procalcitonin Sales (2019-2024)
3.3 Global Top Players by Procalcitonin Price (2019-2024)
3.4 Global Procalcitonin Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Procalcitonin Key Company Manufacturing Sites & Headquarters
3.6 Global Procalcitonin Company, Product Type & Application
3.7 Global Procalcitonin Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Procalcitonin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2023
3.8.3 2023 Procalcitonin Tier 1, Tier 2, and Tier 3
4 Procalcitonin Regional Status and Outlook
4.1 Global Procalcitonin Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Procalcitonin Historic Market Size by Region
4.2.1 Global Procalcitonin Sales in Volume by Region (2019-2024)
4.2.2 Global Procalcitonin Sales in Value by Region (2019-2024)
4.2.3 Global Procalcitonin Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Procalcitonin Forecasted Market Size by Region
4.3.1 Global Procalcitonin Sales in Volume by Region (2025-2030)
4.3.2 Global Procalcitonin Sales in Value by Region (2025-2030)
4.3.3 Global Procalcitonin Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Procalcitonin by Application
5.1 Procalcitonin Market by Application
5.1.1 Medical Industry
5.1.2 Scientific Research
5.1.3 Veterinarian
5.2 Global Procalcitonin Market Size by Application
5.2.1 Global Procalcitonin Market Size Overview by Application (2019-2030)
5.2.2 Global Procalcitonin Historic Market Size Review by Application (2019-2024)
5.2.3 Global Procalcitonin Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Procalcitonin Sales Breakdown by Application (2019-2024)
5.3.2 Europe Procalcitonin Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Procalcitonin Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Procalcitonin Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Procalcitonin Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Thermo Fisher
6.1.1 Thermo Fisher Comapny Information
6.1.2 Thermo Fisher Business Overview
6.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Procalcitonin Product Portfolio
6.1.5 Thermo Fisher Recent Developments
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Comapny Information
6.2.2 Roche Diagnostics Business Overview
6.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Diagnostics Procalcitonin Product Portfolio
6.2.5 Roche Diagnostics Recent Developments
6.3 bioMerieux
6.3.1 bioMerieux Comapny Information
6.3.2 bioMerieux Business Overview
6.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 bioMerieux Procalcitonin Product Portfolio
6.3.5 bioMerieux Recent Developments
6.4 HyTest
6.4.1 HyTest Comapny Information
6.4.2 HyTest Business Overview
6.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HyTest Procalcitonin Product Portfolio
6.4.5 HyTest Recent Developments
6.5 BBI Solutions
6.5.1 BBI Solutions Comapny Information
6.5.2 BBI Solutions Business Overview
6.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BBI Solutions Procalcitonin Product Portfolio
6.5.5 BBI Solutions Recent Developments
6.6 ProSpec
6.6.1 ProSpec Comapny Information
6.6.2 ProSpec Business Overview
6.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ProSpec Procalcitonin Product Portfolio
6.6.5 ProSpec Recent Developments
6.7 Wondfo
6.7.1 Wondfo Comapny Information
6.7.2 Wondfo Business Overview
6.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Wondfo Procalcitonin Product Portfolio
6.7.5 Wondfo Recent Developments
6.8 Ningbo Medicalsystem Biotechnology
6.8.1 Ningbo Medicalsystem Biotechnology Comapny Information
6.8.2 Ningbo Medicalsystem Biotechnology Business Overview
6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
6.9 Wuhan Easy Diagnosis Biomedicine
6.9.1 Wuhan Easy Diagnosis Biomedicine Comapny Information
6.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
6.10 Snibe
6.10.1 Snibe Comapny Information
6.10.2 Snibe Business Overview
6.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Snibe Procalcitonin Product Portfolio
6.10.5 Snibe Recent Developments
6.11 Vazyme Biotech
6.11.1 Vazyme Biotech Comapny Information
6.11.2 Vazyme Biotech Business Overview
6.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vazyme Biotech Procalcitonin Product Portfolio
6.11.5 Vazyme Biotech Recent Developments
6.12 Getein Biotech
6.12.1 Getein Biotech Comapny Information
6.12.2 Getein Biotech Business Overview
6.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Getein Biotech Procalcitonin Product Portfolio
6.12.5 Getein Biotech Recent Developments
6.13 Hotgen Biotech
6.13.1 Hotgen Biotech Comapny Information
6.13.2 Hotgen Biotech Business Overview
6.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hotgen Biotech Procalcitonin Product Portfolio
6.13.5 Hotgen Biotech Recent Developments
6.14 Lumigenex
6.14.1 Lumigenex Comapny Information
6.14.2 Lumigenex Business Overview
6.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lumigenex Procalcitonin Product Portfolio
6.14.5 Lumigenex Recent Developments
6.15 Nanjing Norman Biological Technology
6.15.1 Nanjing Norman Biological Technology Comapny Information
6.15.2 Nanjing Norman Biological Technology Business Overview
6.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
6.15.5 Nanjing Norman Biological Technology Recent Developments
6.16 Kitgen
6.16.1 Kitgen Comapny Information
6.16.2 Kitgen Business Overview
6.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kitgen Procalcitonin Product Portfolio
6.16.5 Kitgen Recent Developments
6.17 Beijing KeyGen
6.17.1 Beijing KeyGen Comapny Information
6.17.2 Beijing KeyGen Business Overview
6.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Beijing KeyGen Procalcitonin Product Portfolio
6.17.5 Beijing KeyGen Recent Developments
6.18 Beijing Apis
6.18.1 Beijing Apis Comapny Information
6.18.2 Beijing Apis Business Overview
6.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Apis Procalcitonin Product Portfolio
6.18.5 Beijing Apis Recent Developments
7 North America by Country
7.1 North America Procalcitonin Sales by Country
7.1.1 North America Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Procalcitonin Sales by Country (2019-2024)
7.1.3 North America Procalcitonin Sales Forecast by Country (2025-2030)
7.2 North America Procalcitonin Market Size by Country
7.2.1 North America Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Procalcitonin Market Size by Country (2019-2024)
7.2.3 North America Procalcitonin Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Procalcitonin Sales by Country
8.1.1 Europe Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Procalcitonin Sales by Country (2019-2024)
8.1.3 Europe Procalcitonin Sales Forecast by Country (2025-2030)
8.2 Europe Procalcitonin Market Size by Country
8.2.1 Europe Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Procalcitonin Market Size by Country (2019-2024)
8.2.3 Europe Procalcitonin Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Procalcitonin Sales by Country
9.1.1 Asia-Pacific Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Procalcitonin Sales by Country (2019-2024)
9.1.3 Asia-Pacific Procalcitonin Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Procalcitonin Market Size by Country
9.2.1 Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Procalcitonin Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Procalcitonin Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Procalcitonin Sales by Country
10.1.1 Latin America Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Procalcitonin Sales by Country (2019-2024)
10.1.3 Latin America Procalcitonin Sales Forecast by Country (2025-2030)
10.2 Latin America Procalcitonin Market Size by Country
10.2.1 Latin America Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Procalcitonin Market Size by Country (2019-2024)
10.2.3 Latin America Procalcitonin Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Procalcitonin Sales by Country
11.1.1 Middle East and Africa Procalcitonin Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Procalcitonin Sales by Country (2019-2024)
11.1.3 Middle East and Africa Procalcitonin Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Procalcitonin Market Size by Country
11.2.1 Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Procalcitonin Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Procalcitonin Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Procalcitonin Value Chain Analysis
12.1.1 Procalcitonin Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Procalcitonin Production Mode & Process
12.2 Procalcitonin Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Procalcitonin Distributors
12.2.3 Procalcitonin Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings